LENEXA, Kan., May 11, 2005 (PRIMEZONE) -- Mediware Information Systems, Inc. (Nasdaq:MEDW), an acknowledged leader in clinical information and patient safety software management solutions, announced today that Yale-New Haven Hospital signed a contract to license Mediware's HCLL(tm) Transfusion software system to manage its transfusion services.
Melanie Champion, MT (ASCP) SBB HP, manager, Blood Bank Laboratory at Yale-New Haven, said, "I am looking forward to continuing our relationship with Mediware as we move to the HCLL(tm) Transfusion software system. We chose to stay with Mediware because of the company's experience with blood bank software systems and its commitment to improving patient safety and maintaining data integrity. We are confident that the HCLL(tm) Transfusion software system will meet our needs for many years to come."
Frank Poggio, vice president & general manager of Mediware's Blood Bank division, commented on the importance of preserving data, saying, "Accurate and reliable data preservation is always a critical factor in patient safety and a vital element in the decision-making process when considering a new transfusion system." Poggio added, "We are very pleased that a healthcare leader like Yale-New Haven has chosen to continue to partner with Mediware and install our state-of-the-art HCLL(tm) Transfusion software system. We look forward to providing Yale-New Haven with a complete and safe transition to our transfusion system."
About Yale-New Haven Hospital
Yale-New Haven Hospital (YNHH) is a 944-bed tertiary referral center that includes the 201-bed Yale-New Haven Children's Hospital and the 76-bed Yale-New Haven Psychiatric Hospital. It is also the primary teaching hospital for the Yale University School of Medicine (YSM). Yale-New Haven provides services for close to 50,000 inpatients and has over half a million outpatient visits a year. YNHH is affiliated with the Yale Cancer Center, one of the National Cancer Institute's 39 comprehensive cancer centers in the US.
About Mediware
Mediware provides clinical information systems for hospitals and integrated healthcare delivery systems. Its products include HCLL(tm) Transfusion, LifeTrak(r), IIE(tm) (Instrument Interface Engine), Hemocare(r), LifeLine(tm) (Blood Bank), WORx(r), MediCOE(tm), MediMAR(tm), Pharmakon(r), and Digimedics(tm) (Medication Management), Surgiware(tm) and Perioperative Solutions(tm) (Operating Room), as well as the JAC Stock Control System (pharmacy) in the United Kingdom. Mediware has over 1,100 systems installed in the US, Canada, the UK, and elsewhere.
Certain statements in this press release may constitute "forward-looking" statements within the meaning of the Private Securities Litigation Reform Act of 1995, as the same may be amended from time to time (the "Act") and in releases made by the SEC from time to time. Such forward-looking statements are not based on historical facts and involve known and unknown risks, uncertainties and other factors disclosed in the Company's Annual Report on Form 10-K for the year ended June 30, 2004, which may cause the actual results of the Company to be materially different from any future results expressed or implied by such forward-looking statements. The Company disclaims any obligation to update its forward-looking statements.